5 Fastest Growing Biotech Companies in the US

4. CureVac N.V. (NASDAQ: CVAC)

Headquarters: Tuebingen, Germany.

No. of employees: 500

Revenue (2018): $12.9 million

Revenue (2019): $17.4 million

Founded in 2000, CureVac N.V. is a biopharmaceutical company that is engaged in developing messenger ribonucleic acid(mRNA) vaccines and drugs for treating cancer, infectious diseases and rare diseases.

The company’s pipeline primarily targets three domains: prophylactic vaccines, cancer immunotherapy, and protein-based therapy. Its major clinical programs entail ‘CV8102’ for treating four types of solid tumors, and ‘CV7202’ for potential vaccination against rabies.

The company initiated the Phase III trial of its Covid-19 vaccine ‘CVnCoV’ which is an optimized, non-chemically modified mRNA.